Geode Capital Management’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
Geode Capital Management's SOPH Position: Q2 2026 in Review
Geode Capital Management increased its SOPHiA GENETICS (SOPH) stake by 7.6% in Q2 2026, buying an estimated $35.4K and bringing the position to 99,124 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #3543.
Geode Capital Management first reported a position in SOPH in Q4 2021 and has held it in 19 quarters since. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- Geode Capital Management held 99,124 shares of SOPHiA GENETICS worth $572K as of Q2 2026.
- Geode Capital Management bought 6,978 SOPHiA GENETICS shares in Q2 2026, an estimated $35.4K.
- SOPHiA GENETICS made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3543 holding.
- Geode Capital Management first reported a position in SOPHiA GENETICS in Q4 2021 and has held it in 19 quarters since.
- 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.